Profil Financier
Hua Xuande & family occupe actuellement le rang #2873 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.3 B (+$36 sur 24h).
Hua Xuande chairs Zhejiang ZoneBanner Jiuzhou Group, which controls Shanghai-listed pharmaceutical supplier Zhejiang Jiuzhou Pharmaceutical.
Hua's daughter, Hua Lirong, chairs Zhejiang Jiuzhou Pharmaceutical.
In September 2019, Jiuzhou Pharmaceutical acquired U.S. pharmaceutical ingredient firm PharmAgra Labs for a reported $16 million.
In 2019 Jiuzhou also took over a Chinese subsidiary of Swiss pharmaceutical maker Novartis to help expand its production.